<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36694130</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1528-3658</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Molecular medicine (Cambridge, Mass.)</Title><ISOAbbreviation>Mol Med</ISOAbbreviation></Journal><ArticleTitle>Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning.</ArticleTitle><Pagination><StartPage>12</StartPage><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-023-00603-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a rare progressive neurodegenerative disease that affects upper and lower motor neurons. As the molecular basis of the disease is still elusive, the development of high-throughput sequencing technologies, combined with data mining techniques and machine learning methods, could provide remarkable results in identifying pathogenetic mechanisms. High dimensionality is a major problem when applying machine learning techniques in biomedical data analysis, since a huge number of features is available for a limited number of samples. The aim of this study was to develop a methodology for training interpretable machine learning models in the classification of ALS and ALS-subtypes samples, using gene expression datasets.</AbstractText><AbstractText Label="METHODS">We performed dimensionality reduction in gene expression data using a semi-automated preprocessing systematic gene selection procedure using Statistically Equivalent Signature (SES), a causality-based feature selection algorithm, followed by Boosted Regression Trees (XGBoost) and Random Forest to train the machine learning classifiers. The SHapley Additive exPlanations (SHAP values) were used for interpretation of the machine learning classifiers. The methodology was developed and tested using two distinct publicly available ALS RNA-seq datasets. We evaluated the performance of SES as a dimensionality reduction method against: (a) Least Absolute Shrinkage and Selection Operator (LASSO), and (b) Local Outlier Factor (LOF).</AbstractText><AbstractText Label="RESULTS">The proposed methodology achieved 85.18% accuracy for the classification of cerebellum or frontal cortex samples as C9orf72-related familial ALS, sporadic ALS or healthy samples. Importantly, the genes identified as the most determinative have also been reported as disease-associated in ALS literature. When tested in the evaluation dataset, the methodology achieved 88.89% accuracy for the classification of sporadic ALS motor neuron samples. When LASSO was used as feature selection method instead of SES, the accuracy of the machine learning classifiers ranged from 74.07 to 96.30%, depending on tissue assessed, while LOF underperformed significantly (77.78% accuracy for the classification of pooled cerebellum and frontal cortex samples).</AbstractText><AbstractText Label="CONCLUSIONS">Using SES, we addressed the challenge of high dimensionality in gene expression data analysis, and we trained accurate machine learning ALS classifiers, specific for the gene expression patterns of different disease subtypes and tissue samples, while identifying disease-associated genes.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Founta</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, NY, 11549, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, School of Health Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dafou</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanata</LastName><ForeName>Eirini</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, School of Health Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sklaviadis</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, School of Health Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanos</LastName><ForeName>Theodoros P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Hempstead, NY, 11549, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Feinstein Institutes for Medical Research, Institute of Health Systems Science, Northwell Health, Manhasset, NY, 11030, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gounaris</LastName><ForeName>Anastasios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Informatics, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xanthopoulos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8759-8962</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, School of Health Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. xantho@pharm.auth.gr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research and Technology Hellas, 57001, Thermi, Greece. xantho@pharm.auth.gr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Med</MedlineTA><NlmUniqueID>9501023</NlmUniqueID><ISSNLinking>1076-1551</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018390" MajorTopicYN="N">Gene Targeting</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Causality-based feature selection</Keyword><Keyword MajorTopicYN="N">Dimensionality reduction</Keyword><Keyword MajorTopicYN="N">Gene expression</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36694130</ArticleId><ArticleId IdType="pmc">PMC9872307</ArticleId><ArticleId IdType="doi">10.1186/s10020-023-00603-y</ArticleId><ArticleId IdType="pii">10.1186/s10020-023-00603-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anna Roumpelaki KB. Package &#x201c;MXM&#x201d; Type Package Title Feature Selection (Including Multiple Solutions) and Bayesian Networks. 2022. https://cran.r-project.org/web/packages/MXM/MXM.pdf</Citation></Reference><Reference><Citation>Aronica E, Baas F, Iyer A, ten Asbroek ALMA, Morello G, Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol Dis. 2015;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Barredo Arrieta A, D&#xed;az-Rodr&#xed;guez N, Del Ser J, Bennetot A, Tabik S, Barbado A, et al. Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI. Inf Fusion. 2020;1(58):82&#x2013;115. doi: 10.1016/j.inffus.2019.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.inffus.2019.12.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra R, Hutt K, Vu A, Rabin SJ, Baughn MW, Libby RT, et al. Gene Expression Signatures of Sporadic ALS Motor Neuron Populations. Neuroscience. 2016 doi: 10.1101/038448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/038448</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean DM, Al-Chalabi A, Dobson RJB, Iacoangeli A. A knowledge-based machine learning approach to gene prioritisation in amyotrophic lateral sclerosis. Genes. 2020;11(6):668. doi: 10.3390/genes11060668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11060668</ArticleId><ArticleId IdType="pmc">PMC7349022</ArticleId><ArticleId IdType="pubmed">32575372</ArticleId></ArticleIdList></Reference><Reference><Citation>Berge T, Eriksson A, Brorson IS, H&#xf8;gest&#xf8;l EA, Berg-Hansen P, D&#xf8;skeland A, et al. Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls. Clin Proteomics. 2019;16(1):19. doi: 10.1186/s12014-019-9241-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-019-9241-5</ArticleId><ArticleId IdType="pmc">PMC6505067</ArticleId><ArticleId IdType="pubmed">31080378</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessodes N, Parain K, Bronchain O, Bellefroid EJ, Perron M. Prdm13 forms a feedback loop with Ptf1a and is required for glycinergic amacrine cell genesis in the Xenopus Retina. Neural Develop. 2017;12(1):16. doi: 10.1186/s13064-017-0093-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13064-017-0093-2</ArticleId><ArticleId IdType="pmc">PMC5580440</ArticleId><ArticleId IdType="pubmed">28863786</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Breiman and Cutler&#x2019;s random forests for classification and regression. Mach Learn. 2001;45(1):5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco: ACM; 2016. p. 785&#x2013;94.</Citation></Reference><Reference><Citation>Cicardi ME, Cristofani R, Rusmini P, Meroni M, Ferrari V, Vezzoli G, et al. Tdp-25 routing to autophagy and proteasome ameliorates its aggregation in amyotrophic lateral sclerosis target cells. Sci Rep. 2018;8(1):12390. doi: 10.1038/s41598-018-29658-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29658-2</ArticleId><ArticleId IdType="pmc">PMC6098007</ArticleId><ArticleId IdType="pubmed">30120266</ArticleId></ArticleIdList></Reference><Reference><Citation>DeglInnocenti D, Ramazzotti M, Sarchielli E, Monti D, Chevanne M, Vannelli GB, et al. Oxadiazon affects the expression and activity of aldehyde dehydrogenase and acylphosphatase in human striatal precursor cells: A possible role in neurotoxicity. Toxicology. 2019;411:110&#x2013;121. doi: 10.1016/j.tox.2018.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2018.10.021</ArticleId><ArticleId IdType="pubmed">30391265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkova-Kostova AT, Kostov RV, Kazantsev AG. The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J. 2018;285(19):3576&#x2013;3590. doi: 10.1111/febs.14379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14379</ArticleId><ArticleId IdType="pmc">PMC6221096</ArticleId><ArticleId IdType="pubmed">29323772</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenstein M. Machine learning powers biobank-driven drug discovery. Nat Biotechnol. 2022;40:1303&#x2013;1305. doi: 10.1038/s41587-022-01457-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01457-1</ArticleId><ArticleId IdType="pubmed">36050552</ArticleId></ArticleIdList></Reference><Reference><Citation>Errico F, Cuomo M, Canu N, Caputo V, Usiello A. New insights on the influence of free d-aspartate metabolism in the mammalian brain during prenatal and postnatal life. Biochim Biophys Acta BBA - Proteins Proteomics. 2020;1868(10):140471. doi: 10.1016/j.bbapap.2020.140471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2020.140471</ArticleId><ArticleId IdType="pubmed">32561430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Chan CKK. Analysis of RNA-Seq data using tophat and cufflinks. Methods Mol Biol Clifton NJ. 2016;1374:339&#x2013;361. doi: 10.1007/978-1-4939-3167-5_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3167-5_18</ArticleId><ArticleId IdType="pubmed">26519415</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368&#x2013;380. doi: 10.1016/S1474-4422(13)70026-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70026-7</ArticleId><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Higa L, Zhang H. Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy. Cell Div. 2007;2(1):5. doi: 10.1186/1747-1028-2-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1747-1028-2-5</ArticleId><ArticleId IdType="pmc">PMC1805432</ArticleId><ArticleId IdType="pubmed">17280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G, Leigh PN, Newbury SF, Hafezparast M. An overview of MicroRNAs as biomarkers of ALS. Front Neurol. 2019;7(10):186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim A, Su Z, West PK, Keon M, Shamsani J, et al. Molecular classification and interpretation of amyotrophic lateral sclerosis using deep convolution neural networks and shapley values. Genes. 2021;12(11):1754. doi: 10.3390/genes12111754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12111754</ArticleId><ArticleId IdType="pmc">PMC8626003</ArticleId><ArticleId IdType="pubmed">34828360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotni MK, Zhao M, Wei DQ. Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation. Orphanet J Rare Dis. 2016;11(1):148. doi: 10.1186/s13023-016-0531-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-016-0531-y</ArticleId><ArticleId IdType="pmc">PMC5097384</ArticleId><ArticleId IdType="pubmed">27814735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagani V, Athineou G, Farcomeni A, Tsagris M, Tsamardinos I. Feature Selection with the R Package MXM : Discovering Statistically Equivalent Feature Subsets. J Stat Softw. 2017;80:7. doi: 10.18637/jss.v080.i07.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v080.i07</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics. 2007;8(1):26. doi: 10.1186/1471-2164-8-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-8-26</ArticleId><ArticleId IdType="pmc">PMC1796866</ArticleId><ArticleId IdType="pubmed">17244347</ArticleId></ArticleIdList></Reference><Reference><Citation>Leszczy&#x144;ski P, &#x15a;miech M, Parvanov E, Watanabe C, Mizutani K, Taniguchi H. Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors) Cells. 2020;9(12):2603. doi: 10.3390/cells9122603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9122603</ArticleId><ArticleId IdType="pmc">PMC7761934</ArticleId><ArticleId IdType="pubmed">33291744</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Shi F, Wang G, Lv J, Zhang H, Jin H, et al. Expression profile of immunoglobulin G glycosylation in children with epilepsy in Han nationality. Front Mol Neurosci. 2022;1(15):843897. doi: 10.3389/fnmol.2022.843897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2022.843897</ArticleId><ArticleId IdType="pmc">PMC9283856</ArticleId><ArticleId IdType="pubmed">35845609</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D&#x2019;Errico E, et al. Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci. 2018;28(11):288. doi: 10.3389/fnmol.2018.00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Venugopal S, Majid S, Ahn IS, Diamante G, Hong J, et al. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis. Neurobiol Dis. 2020;141:104877. doi: 10.1016/j.nbd.2020.104877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104877</ArticleId><ArticleId IdType="pmc">PMC7519882</ArticleId><ArticleId IdType="pubmed">32360664</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffreda A, Nizzardo M, Arosio A, Ruepp MD, Calogero RA, Volinia S, et al. miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis. Prog Neurobiol. 2020;190:101803. doi: 10.1016/j.pneurobio.2020.101803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101803</ArticleId><ArticleId IdType="pubmed">32335272</ArticleId></ArticleIdList></Reference><Reference><Citation>Magen I, Yacovzada N, Warren JD, Heller C, Swift I, Bobeva Y, et al. microRNA-based predictor for diagnosis of frontotemporal dementia. Neurology. 2020 doi: 10.1101/2020.01.22.20018408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.01.22.20018408</ArticleId><ArticleId IdType="pubmed">37317649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL. Genetics of amyotrophic lateral sclerosis: A review. J Neurol Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;6(13):1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SJ, Glatzer JC, Hsieh YC, Rothstein JD. Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model. J Neurogenet. 2018;32(4):322&#x2013;335. doi: 10.1080/01677063.2018.1513508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2018.1513508</ArticleId><ArticleId IdType="pmc">PMC6444185</ArticleId><ArticleId IdType="pubmed">30398075</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G, Guarnaccia M, Spampinato AG, La Cognata V, D&#x2019;Agata V, Cavallaro S. Copy number variations in amyotrophic lateral sclerosis: piecing the mosaic tiles together through a systems biology approach. Mol Neurobiol. 2017;55(2):1299&#x2013;1322. doi: 10.1007/s12035-017-0393-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0393-x</ArticleId><ArticleId IdType="pmc">PMC5820374</ArticleId><ArticleId IdType="pubmed">28120152</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G, Guarnaccia M, Spampinato AG, La Cognata V, D&#x2019;Agata V, Cavallaro S. Copy number variations in amyotrophic lateral sclerosis: piecing the mosaic tiles together through a systems biology approach. Mol Neurobiol. 2018;55(2):1299&#x2013;1322. doi: 10.1007/s12035-017-0393-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0393-x</ArticleId><ArticleId IdType="pmc">PMC5820374</ArticleId><ArticleId IdType="pubmed">28120152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Ohnuma T, Hanzawa R, Takebayashi Y, Takeda M, Nishimon S, et al. Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese population. Am J Med Genet B Neuropsychiatr Genet. 2015;168(7):630&#x2013;636. doi: 10.1002/ajmg.b.32347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.32347</ArticleId><ArticleId IdType="pubmed">26175060</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, et al. A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis. Commun Biol. 2020;3(1):526. doi: 10.1038/s42003-020-01251-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01251-2</ArticleId><ArticleId IdType="pmc">PMC7511394</ArticleId><ArticleId IdType="pubmed">32968195</ArticleId></ArticleIdList></Reference><Reference><Citation>Norsk Regnesentral NS. Package &#x2018;shapr&#x2019; Title Prediction Explanation with Dependence-Aware Shapley Values. 2021. https://cran.r-project.org/web/packages/shapr/shapr.pdf</Citation></Reference><Reference><Citation>Pantelidou M, Zographos SE, Lederer CW, Kyriakides T, Pfaffl MW, Santama N. Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiol Dis. 2007;26(3):577&#x2013;589. doi: 10.1016/j.nbd.2007.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.02.005</ArticleId><ArticleId IdType="pubmed">17418584</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994&#x2013;1003. doi: 10.1016/S1474-4422(07)70265-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70265-X</ArticleId><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18(8):1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun FW, Liu BHM, Long X, Leung HW, Leung GHD, Mewborne QT, et al. Identification of therapeutic targets for amyotrophic lateral sclerosis using PandaOmics &#x2013; An AI-Enabled Biological Target Discovery Platform. Front Aging Neurosci. 2022;28(14):914017. doi: 10.3389/fnagi.2022.914017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.914017</ArticleId><ArticleId IdType="pmc">PMC9273868</ArticleId><ArticleId IdType="pubmed">35837482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD. Motor Neuron Susceptibility in ALS/FTD. Front Neurosci. 2019;27(13):532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino E, Di Stefano M, Galimberti D, Serpente M, Scarpini E, Fenoglio C, et al. C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget&#x2019;s disease of bone. Neurobiol Aging. 2020;85:154.e1&#x2013;154.e3. doi: 10.1016/j.neurobiolaging.2019.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.08.014</ArticleId><ArticleId IdType="pubmed">31530427</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris CG, Horvath S, van Vught PW, van Es MA, Blauw HM, Fuller TF, et al. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics. 2009;10(1):405. doi: 10.1186/1471-2164-10-405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-10-405</ArticleId><ArticleId IdType="pmc">PMC2743717</ArticleId><ArticleId IdType="pubmed">19712483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha Q, Zhang Z, Schymick JC, Traynor BJ, Zhang S. Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis. BMC Med Genet. 2009;10(1):86. doi: 10.1186/1471-2350-10-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-10-86</ArticleId><ArticleId IdType="pmc">PMC2752455</ArticleId><ArticleId IdType="pubmed">19740415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Chunduri A, Gopu A, Shatrowsky C, Crusio WE, Delprato A, et al. Common genetic signatures of Alzheimer&#x2019;s disease in Down Syndrome. F1000 Res. 2021;9:1299. doi: 10.12688/f1000research.27096.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27096.2</ArticleId><ArticleId IdType="pmc">PMC7871416</ArticleId><ArticleId IdType="pubmed">33633844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Yamamoto T, Hiroi A, Omi Y, Kato Y, Kobayashi M. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis. Neuropathology. 2010;30(4):353&#x2013;360. doi: 10.1111/j.1440-1789.2009.01078.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01078.x</ArticleId><ArticleId IdType="pubmed">19925559</ArticleId></ArticleIdList></Reference><Reference><Citation>Shtilbans A, Choi SG, Fowkes ME, Khitrov G, Shahbazi M, Ting J, et al. Differential gene expression in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(4):250&#x2013;256. doi: 10.3109/17482968.2011.560946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.560946</ArticleId><ArticleId IdType="pubmed">21375368</ArticleId></ArticleIdList></Reference><Reference><Citation>Silroy U, Bhowal A. Identifying causal genes for Amyotrophic Lateral Sclerosis (ALS) by Meta Analysis of Gene Expression Data. Int J Eng Sci Math. 2018;7(3):89.</Citation></Reference><Reference><Citation>Swindell WR, Kruse CPS, List EO, Berryman DE, Kopchick JJ. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. J Transl Med. 2019;17(1):1&#x2013;33. doi: 10.1186/s12967-019-1909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1909-0</ArticleId><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference><Reference><Citation>Torgo L. Data mining with R: learning with case studies. Second edition. Boca Raton: CRC Press, Taylor &amp; Francis Group; 2017. 405 p. (Chapman &amp; Hall/CRC data mining and knowledge discovery series).</Citation></Reference><Reference><Citation>Van Es MA, Veldink JH, Saris CGJ, Blauw HM, Van Vught PWJ, Birve A, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009;41(10):1083&#x2013;1087. doi: 10.1038/ng.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilopoulou C, Morris AP, Giannakopoulos G, Duguez S, Duddy W. What can machine learning approaches in genomics tell us about the molecular basis of amyotrophic lateral sclerosis? J Pers Med. 2020;10(4):247. doi: 10.3390/jpm10040247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10040247</ArticleId><ArticleId IdType="pmc">PMC7712791</ArticleId><ArticleId IdType="pubmed">33256133</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk AE, Weishaupt JH, Andersen PM, Ludolph AC, Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med Genet. 2018;30(2):252&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Huh SU, Drennan JM, Kathuria H, Martinez JS, Tsuda H, et al. Drosophila Vap-33 Is required for axonal localization of Dscam isoforms. J Neurosci. 2012;32(48):17241&#x2013;17250. doi: 10.1523/JNEUROSCI.2834-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2834-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621857</ArticleId><ArticleId IdType="pubmed">23197716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Jiao B, Shen L. The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders. Front Genet. 2020;2(11):1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492664</ArticleId><ArticleId IdType="pubmed">32983232</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu K, Guo X, Liu L, Li J, Wang H, Ling Z, et al. Causality-based Feature Selection: Methods and Evaluations. ACM Comput Surv. 2020;53(5):28.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Cooper-Knock J, Weimer AK, Shi M, Moll T, Marshall JNG, et al. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. Neuron. 2022;110(6):992&#x2013;1008.e11. doi: 10.1016/j.neuron.2021.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.12.019</ArticleId><ArticleId IdType="pmc">PMC9017397</ArticleId><ArticleId IdType="pubmed">35045337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff OJ, Clarke BE, Taha DM, Crerar H, Luscombe NM, Patani R. Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states. Genome Res. 2022;32(1):71&#x2013;84. doi: 10.1101/gr.275939.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.275939.121</ArticleId><ArticleId IdType="pmc">PMC8744676</ArticleId><ArticleId IdType="pubmed">34963663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>